Chief and Senior Consultant ENT Surgeon/ Associate Professor (NUS)
MBBS FRCS
Dr Loh graduated from the Faculty of Medicine, National University of Singapore. He underwent residency in Otolaryngology at the National University Hospital and subsequently trained in Head and Neck Cancer Surgery at the Princess Margaret Hospital and Toronto General Hospital in Canada. He is currently a Consultant in Otolaryngology, with his practice mainly in Head and Neck Oncology.
Dr Loh sees mainly patients with head and neck cancers. His practice is in patients with cancers of the oral cavity, pharynx, larynx, thyroid and other sites. The majority of his cancer patients have nasopharyngeal carcinoma (NPC), the most common head and neck cancer in Singapore. He leads the Head and Neck Tumour Board, where radiation and medical oncologists together with surgical oncologists decide on the stage and the treatment for the cancer patients. Dr Loh performs surgery of the thyroid gland and parotid salivary gland and other major complicated surgery to treat cancers of the oral cavity, pharynx and larynx. Where it is suitable, he also treats cancer of the larynx using laser surgery. He also performs complicated tumours of the anterior skull base, or tumours at the junction just below the brain.
Dr Loh is the Chief of Department and leads a large group of specialists as well as research staff in the Department. He also mentors a constant stream of elective students from overseas ranging from Australia to England, Netherlands and Germany just to name a few. He is a member of the Specialist Training Committee that oversees the Otolaryngology speciality in Singapore. He was awarded the Yong Yoo Lin School of Medicine Faculty Teaching Excellence Award and the NUS University Teaching Excellence Award in 2006 in recognition of his contribution to medical undergraduate teaching in NUS.
Dr Loh is also active in research. His main research is in the area of early diagnosis on NPC. He is the current Principle Investigator of 3 grants and a key collaborator in at least another 10 other concurrent studies. His research is focused on a screening programme for first-degree relatives of NPC patients. He has written chapters in textbooks and reference manuals on nasopharyngeal carcinoma. Dr Loh has multiple collaborations with other Departments in the School of Medicine, NUS as well as other renowned institutions such as Division of Biomedical Sciences, Johns Hopkins Singapore.
Visit our NUH Website